维普期刊资源整合服务平台（V6.5）

102篇 您的检索式：作者名="Bi LC"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty显示文摘	Eriksson BI Borris LC Friedman RJ		0，，26：	1
2	Rivaroxaban versus enoxaparin for thromboprophylaxis after hip anthroplasty显示文摘	Eriksson BI Borris LC Friedman RJ	2008	N EnglJ Med2008，358，：	1
3	Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthropl asty 显示文摘	ERIKSSON BI BORRIS LC FRIEDMAN RJ	2008	N Engl J Med2008，358，26：	1
4	A once-daily,oral,direct factor Xa inhibitor,rivaroxaban (BAY 5927939),for thromboprophylaxis after total hip replacement显示文摘	Eriksson BI Borris LC Dahl OE		0，，：	1
5	Rivaroxaban versus enox- aparin for thromboprophylaxis after hip arthroplasty显示文摘	Eriksson BI Borris LC Friedman RJ	2008	N Engl J Med2008，358，26：	1
6	Rivaroxaban versus enox- aparin for thromboprophylaxis after hip arthroplasty 显示文摘	Eriksson BI Borris LC Friedman RJ	2008	N Engl JMed2008，358，26：	1
7	Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty显示文摘	Eriksson BI Borris LC Friedman RJ	2008	N Engl J Mea2008，358，26：	1
8	A once-daily,oral,direct Factor Xa inhibitor,rivaroxaban (BAY 59-7939),for thromboprophylaxis after total hip replacement显示文摘	Eriksson BI Borris LC Dahl OE	2006	Circulation2006，114，22：	1
9	Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty显示文摘	Eriksson BI Bon'is LC Friedman RJ	2008	N En- gl J Med2008，358，26：	1
10	Gastroduodenal mucosal defense:an integrated protective response显示文摘	Bi LC Kaunitz JD	2003	Current Opinion in Gastroenterology2003，19，6：	1
11	Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthro- plasty显示文摘	Eriksson BI Borris LC Fri edman RJ et a/	2008	N Engl J Med2008，358，26：	1
12	Rivaroxa ban versus enoxaparin for thromboprophylaxis after hip arthroplasty显示文摘	Eriksson BI Borris LC Friedman RJ	2008	N Engl J Med2008，358，26：	1
13	Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthro- plasty显示文摘	Eriksson BI Borris LC Friedman R J	2008	N Engl J Med2008，358，26：	1
14	Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplas- ty 显示文摘	Eriksson BI Borris LC Friedman ILl	2008	N Engl J Med2008，358，：	1
15	Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty显示文摘	Eriksson BI Borris LC Friedman RJ	2008	N Engl J Med2008，358，26：	1
16	Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty显示文摘	Eriksson BI Borris LC Friedman RJ	2008	N Engl J Med2008，358，26：	1
17	Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty显示文摘	Eriksson BI Borris LC Friedman RJ	2008	N Engl J Med2008，358，26：	1
18	Novel sinomeninederivative 1032 improves immune suppression in experimental autoimmune encephalomyelitis显示文摘	Yan LC Bi EG Lou YT	2010	Biochem Biophys Res Commun2010，391，1：	1
19	Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral,direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement显示文摘	Eriksson BI Borris LC Dahl OE		0，，05：	1
20	Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty显示文摘	Eriksson BI Borris LC Friedman RJ		0，，26：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示